Holland & Knight’s Michael Werner talks to Dr. Russell Medford, President and CEO of Salutria Pharmaceuticals, a privately-held biotech company based in Alpharetta Georgia. Dr. Medford is also co-chair of BIO’s Board Standing Committee on Bioethics. Dr. Medford will be providing testimony on Wednesday November 16 to the Presidential Commission for the Study of Bioethical Issues on Principles Regarding Ethical Performance of International Clinical Trials.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
TagsPlant biotechnology Health Care IP biofuels BIO EVENT Intellectual Property biotech industry BIOTECH healthcare BIO Investor Forum agriculture GMOs Benefits of biotech crops Animal biotechnology World Congress health Sustainability Patent Reform Food biotechnology
- Most Popular